Literature DB >> 17554326

Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities'.

Sheila M Gardiner, John Keyte, Terence Bennett.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17554326     DOI： 10.1038/nm0607-661a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.

Authors:  Kengo Sato; Rena Watanabe; Fumiko Itoh; Masayoshi Shichiri; Takuya Watanabe
Journal:  Int J Hypertens       Date:  2013-10-22       Impact factor: 2.420

2.  Salusin-β as a powerful endogenous antidipsogenic neuropeptide.

Authors:  Noriko Suzuki-Kemuriyama; Tae Nakano-Tateno; Yuji Tani; Yukio Hirata; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

3.  Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide.

Authors:  Kazumi Fujimoto; Akinori Hayashi; Yoshio Kodera; Tatsuya Saito; Takuya Toki; Akifumi Ogawa; Yuji Kamata; Koji Takano; Hideki Katakami; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Identification of the salusin-β receptor using proteoliposomes embedded with endogenous membrane proteins.

Authors:  Masayoshi Shichiri; Daisuke Nonaka; Lyang-Ja Lee; Kenji Tanaka
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

5.  Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.

Authors:  Kazumi Fujimoto; Akinori Hayashi; Yuji Kamata; Akifumi Ogawa; Takuya Watanabe; Raishi Ichikawa; Yoshitaka Iso; Shinji Koba; Youichi Kobayashi; Takatoshi Koyama; Masayoshi Shichiri
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.